Seth van Voorhees - 25 Nov 2022 Form 4 Insider Report for NRX Pharmaceuticals, Inc. (NRXP)

Role
CHIEF FINANCIAL OFFICER
Signature
/s/ Seth Van Voorhees
Issuer symbol
NRXP
Transactions as of
25 Nov 2022
Net transactions value
+$18,215
Form type
4
Filing time
28 Nov 2022, 06:42:26 UTC
Previous filing
29 Jun 2022
Next filing
19 Dec 2022
SEC
View on sec.gov
This filing has been restated, see here for the amended filing

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NRXP Common Stock, par value $0.001 per share Purchase $9,762 +8,716 $1.12 8,716 25 Nov 2022 Shares purchased though 401(k) plan
transaction NRXP Common Stock, par value $0.001 per share Purchase $660 +600 +6.9% $1.10 9,316 25 Nov 2022 Shares purchased though 401(k) plan
transaction NRXP Common Stock, par value $0.001 per share Purchase $7,793 +7,021 +75% $1.11 16,377 25 Nov 2022 Shares purchased though 401(k) plan
* An asterisk sign (*) next to the price indicates that the price is likely invalid.